CEO Q&A with Geremy Thomas at Sativa Investments PLC (NEX:SATI)

Sativa Investments PLC (NEX:SATI) Chief Executive Officer Geremy Thomas caught up with DirectorsTalk for an exclusive interview to discuss the research contract with King’s College London, the relevance of its 1000th test at PhytoVista, being the most traded stock on the NEX Exchange and the progress of other projects.


Q1: You made a recent announcement about a research contract with King’s College in London, how does that fit into Sativa Investments’ overall strategy?

A1: It’s important for two reasons, one is that the government is calling for more research to enable them to speed up the availability of medicinal cannabis in the UK so we’re happy to support that request.

Also, from our perspective, it’s important because we believe the licensing is going to be a key part of the business going forward and by having this research commitment with Kings College London, we can go to the Home Office to get one of the first THC-rich cultivation and extraction licenses.

That process is now underway, we are working with the Home Office, we’ve had recent site visits and we’re confident that we’ll get one of those licenses which will be important for the business going forward.


Q2: The 1000th test for your laboratory business Phyto Vista, it’s an interesting milestone but what’s the relevance to the UK market for these laboratory services?

A2: When I was travelling in North America, putting together my thoughts on how this business might take shape, it became apparent to me that the laboratory testing function was actually holding up the growth of that market over there. Every batch of medicinal cannabis, or in their case recreational cannabis, has to be tested for the cannabinoid content, the heavy metals present, pesticides and mycotoxins.

I knew that this was going to form an important part of the UK business and is doing so now for us with the CBD wellness marketplace.

So, 1000 tests for the market is an important milestone for us but also indicates how that business is going to be important to not only from a regulatory point of view but from commercial contribution to our group revenues.


Q3: I understand that you were the most traded stock on the NEX Exchange stock last month, it must be pleasing to see such liquidity?

A3: It is very pleasing and we’re pleased to be supported by the NEX team. I think that fact that we have such a following, it’s a very positive and it’s also an indication of how the market believes alongside with ourselves that this small cannabis business in the UK is going to be big.

I think that we will end up with the biggest medicinal cannabis market in Europe and I’m confident about that because of the population numbers that we have here and the demographics of that population. We have an ageing population, a lot of people here and I think we’ll end up with the one of the biggest medicinal cannabis markets in Europe.


Q4: What else is happening in other projects at the moment for Sativa Investments?

A4: So, we’re interested in distribution so George Botanicals is one of our businesses that is a manufacturer, wholesaler and retailer of CBD wellness products and that business is growing nicely.

We’re also about a launch our Goodbody and Blunt retail business so we’re going to be having these CBD wellness stores on the high street and our strategy is to open three of those under our own steam which we will be announcing, shortly, the first one of those.

Subject to the financial performance of those stores, we’ll then be franchising that opportunity with a target of 100 stores in 2 years. I think that will be a very big distribution point for CBD wellness products in the short term and then as access points for medicinal cannabis in the longer term so that’s a very interesting initiative.

We’ve taken on a guy called Chris Jones as Managing Director of that particular business unit, Chris was responsible for Phones 4U which was a big retailer of mobile phones on the high street and more recently, has been involved in a vaping business that had 119 stores in the UK. So, very relevant experience and we’re looking forward to Chris doing his stuff and make a success of Goodbody and Blunt.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Share on twitter
    Share on linkedin
    Sativa Investments plc

    More articles like this


    CBD as a novel food: the UK’s stance post-Brexit

    The UK FSA’s announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the European Commission during the summer of 2020, who have currently ‘paused’ novel food applications for


    What cannabinoids are found in CBD oils?

    CBD oils can be purely made from seeds or they can be a combination of cannabinoids, flavonoids, and terpenes. Every CBD oil is a little bit different, and you will want to make sure you read the labels


    How the UK CBD industry is thriving in uncertain times

    This year covid-19 has hit hard with far-reaching economic implications for countries around the world. The United Kingdom is no exception as the economy has taken the brunt of the pandemic’s negative effects. However certain markets continue to


    UK CBD market on a high

    Just when you thought the ‘hype’ around CBD adoption was a passing fad, UK’s nascent CBD market happens to be among the few industries maintaining an upward growth amidst the recent COVID-19 pandemic devastation in the UK economy. 


    How to integrate CBD oil into your diet

    The internet is awash with information and testimonies on the benefits of CBD oil and the potential that it has in alleviating a number of ailments. Whether or not some of these claims are true is yet to


    Why should you choose CBD oil?

    Cannabidiol (CBD) is a non-psychoactive yet active chemical component among cannabinoids, a group of compounds found in marijuana plants otherwise known as Cannabis sativa. Conversely, Tetrahydrocannabinol (THC) is the principal psychoactive component that causes an intoxicating sensation. This


    A guide to CBD

    What is CBD? CBD – It’s a relatively new product, but how can it benefit you? Most people haven’t even heard of it and yet it’s starting to appear in conversations around sports, food and beauty products. The

    Sativa Group

    Is CBD oil legal in the UK?

    The legal status of CBD in the UK is reflected in many countries worldwide, with the main difference being the levels of THC allowed in the finished product. CBD has seen such a rapid rise to popularity in

    Sativa Group

    Sativa Group joins the ACI toxicology study

    As part of the Sativa Group PLC (AQUIS:SATI) ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry

    Sativa Group

    A comprehensive guide to CBD in the UK

    CBD is being added to products across the retail spectrum from food to make-up. According to claims by the Centre for Medical Cannabis, six million people in the UK have tried CBD, and this year the industry has

    Sativa Group

    A new cannabis wellness era: A history of CBD

    Cannabis Sativa L. has been utilised for a large variety of ailments, industrial applications, and ceremonial uses for millennia. Evidence gathered from significant ancient sites has revealed that the plant was important, and even sacred, in many societies,

    Sativa Group

    How CBD can help level up your workout

    With gyms closed and group classes relegated to the online world, at-home workouts are the new normal. Feeling a bit lackluster after months of squats in your living room? Want a new solution so you can improve your

    Sativa Group

    What is CBD? How does it work?

    What is CBD? It’s in everything from beauty products to lattes, but those three letters are thrown around so much that you’d be forgiven for not knowing what CBD is, exactly. More importantly, you might be wondering, is CBD safe? Despite how

    Sativa Group

    Sativa Group CSE conditionally approves Sativa Wellness Group

    Sativa Group plc (AQUIS:SATI) has announced that the Canadian Securities Exchange conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously announced, Sativa

    No more posts to show